FDA Approves Penpulimab for Non-Keratinizing Nasopharyngeal Carcinoma

The FDA has approved penpulimab-kcqx (Akeso Biopharma) with cisplatin or carboplatin and gemcitabine for the ...

APRIL 25, 2025